{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:34:43Z","timestamp":1780486483037,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11060-021-03883-8","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T13:02:41Z","timestamp":1637326961000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study"],"prefix":"10.1007","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0446-6898","authenticated-orcid":false,"given":"Adomas","family":"Bunevicius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Pikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Kondziolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dev N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik P.","family":"Sulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-che","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Delabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cifarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Arsanious","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem A.","family":"Dahshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwin","family":"Speckter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjul","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Warnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcuk","family":"Peker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Samanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid El","family":"Hefnawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghusn","family":"Al Sideiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"issue":"Suppl_5","key":"3883_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol 21(Suppl_5):v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150","journal-title":"Neuro Oncol"},{"issue":"10","key":"3883_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"3","key":"3883_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1200\/JCO.2016.70.7562","volume":"35","author":"EP Sulman","year":"2017","unstructured":"Sulman EP, Ismaila N, Armstrong TS et al (2017) Radiation therapy for glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. J Clin Oncol 35(3):361\u2013369. https:\/\/doi.org\/10.1200\/JCO.2016.70.7562","journal-title":"J Clin Oncol"},{"issue":"4","key":"3883_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70(4):299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3883_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18(3):170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z","journal-title":"Nat Rev Clin Oncol"},{"issue":"5897","key":"3883_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807\u20131812. https:\/\/doi.org\/10.1126\/science.1164382","journal-title":"Science"},{"issue":"7","key":"3883_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jfma.2012.01.020","volume":"112","author":"J-L Yan","year":"2013","unstructured":"Yan J-L, Chang C-N, Chuang C-C et al (2013) Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery. J Formos Med Assoc 112(7):416\u2013420. https:\/\/doi.org\/10.1016\/j.jfma.2012.01.020","journal-title":"J Formos Med Assoc"},{"issue":"12","key":"3883_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s11912-020-00978-9","volume":"22","author":"A Bunevicius","year":"2020","unstructured":"Bunevicius A, Miller J, Parsons M (2020) Isocitrate dehydrogenase, patient-reported outcomes, and cognitive functioning of glioma patients: a systematic review. Curr Oncol Rep 22(12):120. https:\/\/doi.org\/10.1007\/s11912-020-00978-9","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"3883_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","volume":"15","author":"AM Molinaro","year":"2019","unstructured":"Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR (2019) Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol 15(7):405\u2013417. https:\/\/doi.org\/10.1038\/s41582-019-0220-2","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3883_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/neuros\/nyy049","volume":"84","author":"F Gessler","year":"2019","unstructured":"Gessler F, Bernstock JD, Braczynski A et al (2019) Surgery for glioblastoma in light of molecular markers: impact of resection and MGMT promoter methylation in newly diagnosed IDH-1 wild-type glioblastomas. Neurosurgery 84(1):190\u2013197. https:\/\/doi.org\/10.1093\/neuros\/nyy049","journal-title":"Neurosurgery"},{"issue":"12","key":"3883_CR11","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1093\/annonc\/mdt388","volume":"24","author":"F-W Kreth","year":"2013","unstructured":"Kreth F-W, Thon N, Simon M et al (2013) Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy\u2020\u2020This study was presented in part (as oral presentations) at the 10th Meeting of the European Association of NeuroOncology (EANO), 6\u20139 September 2012, Marseille, France and at the 2012 Annual Meeting of the Society for NeuroOncology (SNO), 15\u201318 November 2012, Washington, DC, USA. Ann Oncol 24(12):3117\u20133123. https:\/\/doi.org\/10.1093\/annonc\/mdt388","journal-title":"Ann Oncol"},{"key":"3883_CR12","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3389\/fonc.2019.01569","volume":"9","author":"F Marchi","year":"2019","unstructured":"Marchi F, Sahnane N, Cerutti R et al (2019) The impact of surgery in IDH 1 wild type glioblastoma in relation with the MGMT deregulation. Front Oncol 9:1569. https:\/\/doi.org\/10.3389\/fonc.2019.01569","journal-title":"Front Oncol"},{"issue":"15_suppl","key":"3883_CR13","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1200\/JCO.2019.37.15_suppl.2000","volume":"37","author":"MJ Van Den Bent","year":"2019","unstructured":"Van Den Bent MJ, Erridge S, Vogelbaum MA et al (2019) Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p\/19q codeletion. JCO 37(15_suppl):2000\u20132000. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.2000","journal-title":"JCO"},{"issue":"5","key":"3883_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamaoncol.2020.6732","volume":"7","author":"DO Kamson","year":"2021","unstructured":"Kamson DO, Grossman SA (2021) The role of temozolomide in patients with newly diagnosed wild-type IDH, unmethylated MGMT p glioblastoma during the COVID-19 pandemic. JAMA Oncol 7(5):675. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6732","journal-title":"JAMA Oncol"},{"issue":"3","key":"3883_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/neuonc\/not198","volume":"16","author":"AN Tran","year":"2014","unstructured":"Tran AN, Lai A, Li S et al (2014) Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Neuro Oncol 16(3):414\u2013420. https:\/\/doi.org\/10.1093\/neuonc\/not198","journal-title":"Neuro Oncol"},{"issue":"9","key":"3883_CR16","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/cncr.23402","volume":"112","author":"D-S Kong","year":"2008","unstructured":"Kong D-S, Lee J-I, Park K, Kim JH, Lim D-H, Nam D-H (2008) Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 112(9):2046\u20132051. https:\/\/doi.org\/10.1002\/cncr.23402","journal-title":"Cancer"},{"key":"3883_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000466998","volume":"31","author":"A Niranjan","year":"2018","unstructured":"Niranjan A, Monaco EA, Kano H, Flickinger JC, Lunsford LD (2018) Stereotactic radiosurgery in the multimodality management of residual or recurrent glioblastoma multiforme. Prog Neurol Surg 31:48\u201361. https:\/\/doi.org\/10.1159\/000466998","journal-title":"Prog Neurol Surg"},{"issue":"1","key":"3883_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1227\/NEU.0000000000001344","volume":"80","author":"BS Imber","year":"2017","unstructured":"Imber BS, Kanungo I, Braunstein S et al (2017) Indications and efficacy of gamma knife stereotactic radiosurgery for recurrent glioblastoma: 2 decades of institutional experience. Neurosurgery 80(1):129\u2013139. https:\/\/doi.org\/10.1227\/NEU.0000000000001344","journal-title":"Neurosurgery"},{"issue":"3","key":"3883_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11060-017-2478-9","volume":"133","author":"BS Kim","year":"2017","unstructured":"Kim BS, Kong D-S, Seol HJ, Nam D-H, Lee J-I (2017) MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. J Neurooncol 133(3):615\u2013622. https:\/\/doi.org\/10.1007\/s11060-017-2478-9","journal-title":"J Neurooncol"},{"issue":"5","key":"3883_CR20","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ijrobp.2010.12.074","volume":"82","author":"KC Cuneo","year":"2012","unstructured":"Cuneo KC, Vredenburgh JJ, Sampson JH et al (2012) Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 82(5):2018\u20132024. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.074","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3883_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3171\/2018.4.JNS172909","volume":"131","author":"M Sharma","year":"2018","unstructured":"Sharma M, Schroeder JL, Elson P et al (2018) Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery. J Neurosurg 131(2):489\u2013499. https:\/\/doi.org\/10.3171\/2018.4.JNS172909","journal-title":"J Neurosurg"},{"issue":"6","key":"3883_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.wneu.2012.03.024","volume":"78","author":"BS Skeie","year":"2012","unstructured":"Skeie BS, Enger P\u00d8, Br\u00f8gger J et al (2012) \u03b3 knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurg 78(6):658\u2013669. https:\/\/doi.org\/10.1016\/j.wneu.2012.03.024","journal-title":"World Neurosurg"},{"key":"3883_CR23","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/j.wneu.2019.03.193","volume":"127","author":"SAL Morris","year":"2019","unstructured":"Morris SAL, Zhu P, Rao M et al (2019) Gamma knife stereotactic radiosurgery in combination with bevacizumab for recurrent glioblastoma. World Neurosurg. 127:e523\u2013e533. https:\/\/doi.org\/10.1016\/j.wneu.2019.03.193","journal-title":"World Neurosurg."},{"issue":"1","key":"3883_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nec.2020.08.007","volume":"32","author":"A Bunevicius","year":"2021","unstructured":"Bunevicius A, Sheehan JP (2021) Radiosurgery for glioblastoma. Neurosurg Clin N Am 32(1):117\u2013128. https:\/\/doi.org\/10.1016\/j.nec.2020.08.007","journal-title":"Neurosurg Clin N Am"},{"key":"3883_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa019","author":"M Azoulay","year":"2020","unstructured":"Azoulay M, Chang SD, Gibbs IC et al (2020) A Phase I\/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noaa019","journal-title":"Neuro Oncol"},{"issue":"4","key":"3883_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000448924","volume":"94","author":"JM Frischer","year":"2016","unstructured":"Frischer JM, Marosi C, Woehrer A et al (2016) Gamma knife radiosurgery in recurrent glioblastoma. Stereotact Funct Neurosurg 94(4):265\u2013272. https:\/\/doi.org\/10.1159\/000448924","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"3883_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11060-020-03689-0","volume":"152","author":"A Dono","year":"2021","unstructured":"Dono A, Amsbaugh M, Martir M et al (2021) Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma. J Neurooncol 152(1):153\u2013162. https:\/\/doi.org\/10.1007\/s11060-020-03689-0","journal-title":"J Neurooncol"},{"issue":"11","key":"3883_CR28","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. JCO 28(11):1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2009.26.3541","journal-title":"JCO"},{"issue":"2","key":"3883_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0360-3016(99)00507-6","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305. Int J Radiat Oncol Biol Phys 47(2):291\u2013298. https:\/\/doi.org\/10.1016\/s0360-3016(99)00507-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1_2","key":"3883_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.wneu.2010.12.053","volume":"76","author":"RE Elliott","year":"2011","unstructured":"Elliott RE, Parker EC, Rush SC et al (2011) Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg. 76(1_2):128\u2013140. https:\/\/doi.org\/10.1016\/j.wneu.2010.12.053 (discussion 61-62)","journal-title":"World Neurosurg."},{"issue":"10","key":"3883_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens A-C, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"issue":"10172","key":"3883_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0140-6736(18)31791-4","volume":"393","author":"U Herrlinger","year":"2019","unstructured":"Herrlinger U, Tzaridis T, Mack F et al (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG\/NOA-09): a randomised, open-label, phase 3 trial. Lancet 393(10172):678\u2013688. https:\/\/doi.org\/10.1016\/S0140-6736(18)31791-4","journal-title":"Lancet"},{"issue":"2","key":"3883_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11060-011-0744-9","volume":"107","author":"K-J Park","year":"2012","unstructured":"Park K-J, Kano H, Iyer A et al (2012) Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. J Neurooncol 107(2):323\u2013333. https:\/\/doi.org\/10.1007\/s11060-011-0744-9","journal-title":"J Neurooncol"},{"issue":"4","key":"3883_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/nop\/npu028","volume":"1","author":"GM Clark","year":"2014","unstructured":"Clark GM, McDonald AM, Nabors LB et al (2014) Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. Neuro-Oncol Pract 1(4):172\u2013177. https:\/\/doi.org\/10.1093\/nop\/npu028","journal-title":"Neuro-Oncol Pract"},{"key":"3883_CR35","doi-asserted-by":"publisher","DOI":"10.3171\/2019.12.JNS192743","author":"A Bunevicius","year":"2020","unstructured":"Bunevicius A, Sheehan D, Lee Vance M, Schlesinger D, Sheehan JP (2020) Outcomes of Cushing\u2019s disease following Gamma Knife radiosurgery: effect of a center\u2019s growing experience and era of treatment. J Neurosurg. https:\/\/doi.org\/10.3171\/2019.12.JNS192743","journal-title":"J Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03883-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03883-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03883-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T15:07:46Z","timestamp":1638889666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03883-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3883"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03883-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author Dr. REW is a member of the Novalis Circle Expert Board. Other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived given the study design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}